Well, getting Veyonda into a fully funded multi-national adaptive trial for COVID should give NOX a bit of X Factor at the very least.
- Forums
- ASX - By Stock
- NOX
- Ann: September 2021 Quarterly Activities Report and Appendix 4C
Ann: September 2021 Quarterly Activities Report and Appendix 4C, page-14
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.0¢ |
Change
-0.005(5.26%) |
Mkt cap ! $26.30M |
Open | High | Low | Value | Volume |
9.3¢ | 9.3¢ | 9.0¢ | $40.92K | 444.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 58000 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 17494 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 58000 | 0.085 |
1 | 25000 | 0.082 |
3 | 119645 | 0.081 |
3 | 148750 | 0.080 |
2 | 178205 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 17494 | 1 |
0.092 | 10169 | 1 |
0.105 | 250000 | 2 |
0.110 | 61698 | 5 |
0.115 | 2000 | 1 |
Last trade - 16.10pm 31/01/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |